在急性心力衰竭中进行静脉注射尿剂治疗的点尿导滴定:试点随机对照试验
Maryam Khorramshahi Bayat1,2, Wandy Chan1,2, Karen Hay3
1Department of Cardiology, The Prince Charles Hospital, 627 Rode Rd, Brisbane, QLD 4032, Australia.
European heart journal. Quality of care & clinical outcomes
|April 17, 2024
概括
在急性心力衰竭 (AHF) 中,点性尿度 (UNa) 指导的利尿药疗法是可行的和更安全的. 与标准护理相比,这种方法导致更好的脱和更少的不良事件.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 药理学 药理学是指药理学的学科.
背景情况:
- 指导方针建议在急性心力衰竭 (AHF) 中评估利尿反应时点尿度 (UNa).
- 目前没有随机对照试验数据支持这一指导方针建议.
- 进行了一项前性试点试验,以评估在AHF中以UNa指导的尿剂定位的可行性.
研究的目的:
- 研究使用尿点度 (UNa) 来指导急性心力衰竭 (AHF) 患者的利尿疗法的可行性.
- 为了比较UA指导的利尿剂定位与基于AHF临床拥堵的标准护理的疗效和安全性.
主要方法:
- 一个潜在的试点随机对照试验,涉及60名AHF患者 (30个手臂).
- 干预组:循环利尿剂根据UNa水平进行定位 (利尿不足定义为UNa <50 mmol/L).
- 标准护理手臂:根据临床迹象和拥堵症状进行位的利尿剂.
主要成果:
- 经UNa导向的治疗导致急性损伤较少 (20%vs. 50%,P=0.01) 和低血的趋势较少 (7%vs. 27%,P=0.04).
- 接受UNa引导治疗的患者体重减轻较大 (3.3公斤与2.1公斤相比,P=0.01) 并且拥堵得分有所改善 (-4.7与-2.6,P<0.01).
- 显著的症状改善在48小时后在UNa引导组中更频繁 (40%对13.3%,P=0.04);在住院时间,死亡率或再入院方面没有显著差异.
结论:
- 与单独的临床评估相比,在AHF中以UNa指导的尿剂定位是可行的,更安全和更有效的,可以在48小时内降低血压.
- 需要进一步进行大规模试验,以确认这种方法是否能改善患者的整体结果.
更多相关视频
相关概念视频
01:22Heart Failure Drugs: Diuretics
370
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
370
01:16Antihypertensive Drugs: Action of Diuretics
679
Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
679
01:11Renal Failure: Dose Adjustments
88
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
88
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
422
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
422
01:28Antihypertensive Drugs: Potassium-Sparing Diuretics
531
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
531
01:26Regulation of Sodium and Potassium
513
The regulation of sodium and potassium ion concentrations in the human body is a complex process governed primarily by hormones such as aldosterone, antidiuretic hormone (ADH), and atrial natriuretic peptide (ANP).
Sodium Regulation
Sodium ions make up approximately 90% of extracellular cations, with a normal blood plasma concentration of 136–148 mEq/L. A decrease in blood volume and pressure triggers the release of renin from granular cells in the juxtaglomerular complex (JGC), primarily...
Sodium Regulation
Sodium ions make up approximately 90% of extracellular cations, with a normal blood plasma concentration of 136–148 mEq/L. A decrease in blood volume and pressure triggers the release of renin from granular cells in the juxtaglomerular complex (JGC), primarily...
513